Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global human microbiome industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Site trends
2.1.4 Application trends
2.1.5 Disease trends
2.1.6 Product trends
Chapter 3 Human Microbiome Industry Insights
3.1 Industry landscape
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing burden of lifestyle-related diseases and the growing geriatric population
3.2.1.2 Increasing funding initiatives and government program
3.2.1.3 Increasing demand precision medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 Long regulatory pathways and high development costs
3.2.2.2 Ethical and safety concern
3.3 Growth potential analysis
3.3.1 By site
3.3.2 By application
3.3.3 By disease
3.3.4 By product
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Company positioning matrix
4.5 Strategy dashboard, 2022
Chapter 5 Human Microbiome Market, By Site, 2018 - 2032 (USD Million)
5.1 Key trends, by site
5.2 Digestive tract
5.3 Lung
5.4 Reproductive cavity
5.5 Skin
5.6 Other sites
Chapter 6 Human Microbiome Market, By Application, 2018 – 2032 (USD Million)
6.1 Key trends, by application
6.2 Therapeutics
6.3 Diagnostics
Chapter 7 Human Microbiome Market, By Disease, 2018 – 2032 (USD Million)
7.1 Key trends, by disease
7.2 Infectious diseases
7.3 Gastrointestinal diseases
7.4 Endocrine & metabolic diseases
7.5 Cancer
7.6 Cetral nervous system disorder
7.7 Other diseases
Chapter 8 Human Microbiome Market, By Product, 2018 – 2032 (USD Million)
8.1 Key trends, by product
8.2 Drugs
8.3 Probiotics
8.4 Prebiotics
8.5 Diagnostic tests
8.6 Other products
Chapter 9 Human Microbiome Market, By Region, 2018 – 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of MEA
Chapter 10 Company Profiles
10.1 Seres Therapeutics
10.2 Enterome
10.3 Second Genome Inc.
10.4 DuPont
10.5 Synthetic Biologics, Inc.
10.6 Synlogic
10.7 Vedanta Biosciences, Inc.
10.8 Metabiomics Corporation
10.9 MICROBIOME THERAPEUTICS LLC
10.10 4D pharma plc
